An online crowdfunding effort has finally answered a family's pleas for help in determining why their young child has succumbed to a mysterious degenerative neurological syndrome involving involuntary eye movements, microcephaly, involuntary muscle contraction, developmental delay, and progressive neurological decline. The affected threeyear-old girl and her parents underwent whole-exome sequencing to identify the genetic cause of the disease after other medical tests provided no answers. The genomic testing revealed a novel mutation in the tubulin β4A class IVa gene (TUBB4A) that causes mental retardation and severe developmental delays. The research team, led by Noam Shomron of Tel Aviv University, Israel, describes the novel crowdfunding mechanism used to support the research in a research article published in the Journal of Genetics and Genomics. Shomron is among many investigators worldwide who have set up a funding mechanism for families interested in pursuing personalized research projects for rare genetic diseases through the Rare Genomics Institute (http://www.raregenomics.org). "Crowdfunding provides the means for economically disadvantaged patients to pursue a genetic diagnosis for their ailment," stated Shomron in a news release issued by Tel Aviv University. "Our project reached its financial goal of $5,000 within 50 days. We were pleased, to say the least. Crowdfunding is a simple and efficient solution for families with rare genetic diseases who lack private or outside funding sources." -Karyn Hede, News Editor
Another novel gene mutation found for RP
A genomic study involving an extended sixgeneration Louisiana family with impaired vision has revealed a new gene mutation that can lead to retinitis pigmentosa (RP), the underlying cause of progressive vision loss in millions of people worldwide. The recent study, published in the journal Investigative Ophthalmology & Visual Science, found that a mutation in the gene hexokinase 1 (HK1) leads to the condition and is inherited through an autosomal dominant mechanism. One family member was found to carry two copies of the mutant gene and had a severe form of RP. Lead author Stephen Daiger, a member of the Human Genetics Center at The University of Texas Health Science Center at Houston, used a combination of strategies, including
Genomics transforming diagnosis of inherited eye disorders see page 245
Until recently, clinicians faced with a difficult case of suspected congenital eye disease had limited diagnostic options. Visualfield testing can document progressive photoreceptor loss, but an understanding of the underlying cause of vision loss remained elusive. Today, modern genomics offers a panoply of individual genetic tests and broader genomic panels that provide many more diagnostic options for clinicians and patients. Indeed, few medical specialties have benefited more directly from the recent revolution in genomic technology than ophthalmology. Massively parallel sequencing has now been demonstrated to be a potent tool for diagnosing inherited eye disease, and the delineation of mutations that underlie diagnosis is becoming even more relevant owing to dramatic advances in gene therapy for such disorders.
In this themed issue, we present a cross-section of studies across a range of research in ophthalmic genetics. A review by Kristy Lee and Seema Garg of the University of North Carolina,
